ArticleJAMA health forum2023
Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.
Edward W Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it